Drug Profile
Colchicine - Takeda
Alternative Names: Colcrys; MPC-004Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator URL Pharma
- Developer Takeda; URL Pharma
- Class Anti-ischaemics; Antigouts; Antineoplastics; Colchicum alkaloids; Small molecules; Vascular disorder therapies
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Familial Mediterranean fever; Gout
- No development reported Atrial fibrillation